Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V7KJ
|
|||
| Former ID |
DIB003351
|
|||
| Drug Name |
Recombinant Clostridium botulinum A/B vaccine
|
|||
| Synonyms |
Bivalent vaccine (Clostridium botulinum infection), Dynport; Bivalent vaccine (clostridium botulinum), Dynport; RBV A/B vaccine, DynPort; Recombinant Clostridium botulinum A/B vaccine, DynPort
Click to Show/Hide
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Phase 2 | [1] | |
| Company |
US Army Medical Research Institute of Infectious Diseases
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01701999) Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.